Pliant Therapeutics, Inc. (PLRX) Tops Q4 EPS by 1c
Tweet
Share
E-mailGet Alerts PLRX Hot Sheet
Join SI Premium – FREE
Pliant Therapeutics, Inc. (NASDAQ: PLRX) reported Q4 EPS of ($0.38), $0.01 better than the analyst estimate of ($0.39).
For earnings history and earnings-related data on Pliant Therapeutics, Inc. (PLRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- KeyBanc Downgrades Primoris Services Corporation (PRIM) to Sector Weight
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Keurig Dr Pepper coffee chief to depart ahead of planned split
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
